Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,863,716
  • Shares Outstanding, K 534,270
  • Annual Sales, $ 10,561 M
  • Annual Income, $ 717,000 K
  • 36-Month Beta 0.77
  • Price/Sales 3.60
  • Price/Cash Flow 18.17
  • Price/Book 4.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.74
  • Number of Estimates 9
  • High Estimate 0.75
  • Low Estimate 0.73
  • Prior Year 0.64
  • Growth Rate Est. (year over year) +15.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.52 +3.27%
on 10/11/18
78.38 -8.41%
on 09/20/18
-5.90 (-7.59%)
since 09/14/18
3-Month
69.52 +3.27%
on 10/11/18
78.38 -8.41%
on 09/20/18
-2.22 (-3.00%)
since 07/16/18
52-Week
62.52 +14.83%
on 02/08/18
78.38 -8.41%
on 09/20/18
+8.14 (+12.79%)
since 10/16/17

Most Recent Stories

More News
What's in Store for Cerner (CERN) This Earnings Season?

Cerner's (CERN) third-quarter 2018 results are likely to be hurt by soft segmental results; guidance promising.

CERN : 64.08 (+2.64%)
MASI : 120.39 (+3.22%)
BAX : 71.59 (+1.02%)
BIO : 290.77 (+4.68%)
Will Instruments Drive Intuitive Surgical (ISRG) Q3 Earnings?

Strong prospects in the Instruments and Accessories segment to drive Intuitive Surgical???s (ISRG) top line in the third quarter of 2018.

MASI : 120.39 (+3.22%)
BIO : 290.77 (+4.68%)
BAX : 71.59 (+1.02%)
ISRG : 539.00 (+3.80%)
Varian Medical (VAR) Q4 Earnings: Is a Surprise in Store?

Solid prospects in the Oncology segment to boost Varian Medical's (VAR) top-line performance in the fourth quarter of fiscal 2018.

VAR : 107.87 (+2.78%)
MASI : 120.39 (+3.22%)
BIO : 290.77 (+4.68%)
BAX : 71.59 (+1.02%)
What's in Store for Express Scripts' (ESRX) Q3 Earnings?

Express Scripts (ESRX) likely to see soft PBM revenues in the third quarter of 2018; guidance strong.

ESRX : 95.98 (+2.63%)
MASI : 120.39 (+3.22%)
BAX : 71.59 (+1.02%)
BIO : 290.77 (+4.68%)
Cerner's Millennium Platform Integrated at McLaren Hospital

Cerner's (CERN) Millennium HCIT platform sees a series of developments in 2018.

CERN : 64.08 (+2.64%)
ATHN : 125.71 (+0.87%)
MDRX : 14.02 (+3.62%)
BAX : 71.59 (+1.02%)
Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?

Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BAX : 71.59 (+1.02%)
Excellent Growth Seen in "Post-Operative Pain Management Market" by 2023 - Competitive Landscape and Revenue Status by Most Prominent Players

VRX.TO : 30.80 (-3.33%)
ENDP : 18.36 (+5.03%)
LLY : 110.69 (+0.06%)
BAX : 71.59 (+1.02%)
NVS : 85.12 (+2.37%)
GSK : 39.71 (+2.13%)
Baxter & ASPEN Launch PN Tools to Boost Clinical Nutrition

Baxter (BAX) and ASPEN's SmartPN lends the company a competitive edge in the MedTech space.

MASI : 120.39 (+3.22%)
BAX : 71.59 (+1.02%)
ISRG : 539.00 (+3.80%)
INGN : 210.99 (+4.61%)
Baxter and ASPEN Launch "SmartPN" Tools to Reinforce Appropriate Use of Parenteral Nutrition

--Adults who are hospitalized and diagnosed with malnutrition have a longer length of stay, higher cost, more comorbidities and 5 times the likelihood of death, compared with other adult inpatient stays(1)...

BAX : 71.59 (+1.02%)
Look for Shares of Baxter Intl Inc to Potentially Rebound after Yesterday's 1.44% Sell Off

Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $72.91 to a high of $74.15. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $73.56...

BAX : 71.59 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade BAX with:

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 72.02
1st Resistance Point 71.45
Last Price 71.59
1st Support Level 70.37
2nd Support Level 69.86

See More

52-Week High 78.38
Fibonacci 61.8% 72.32
Last Price 71.59
Fibonacci 50% 70.45
Fibonacci 38.2% 68.58
52-Week Low 62.52

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar